Perceptive Advisors as of Dec. 31, 2010
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 63 positions in its portfolio as reported in the December 2010 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
D Alexion Pharmaceutic Als Inc C Common Stock 0 | 9.4 | $32M | 402k | 80.56 | |
Cephalon | 9.0 | $31M | 500k | 61.72 | |
Biogen Idec (BIIB) | 7.8 | $27M | 400k | 67.05 | |
Allergan Inc Com Stk | 5.7 | $20M | 285k | 68.67 | |
United Therapeutics Corporation (UTHR) | 5.0 | $17M | 270k | 63.22 | |
Pharmacyclics | 5.0 | $17M | 2.8M | 6.08 | |
Chelsea Therapeutics International | 4.0 | $14M | 1.8M | 7.50 | |
Express Scripts | 3.8 | $13M | 240k | 54.05 | |
Genzyme Corporation | 3.5 | $12M | 170k | 71.20 | |
MannKind Corporation | 3.0 | $11M | 1.3M | 8.06 | |
Salix Pharmaceuticals | 3.0 | $10M | 220k | 46.96 | |
Human Genome Sciences | 2.9 | $10M | 422k | 23.89 | |
Jazz Pharmaceuticals | 2.4 | $8.2M | 416k | 19.68 | |
Celgene Corporation | 2.2 | $7.6M | 129k | 59.14 | |
EXACT Sciences Corporation (EXAS) | 2.2 | $7.6M | 1.3M | 5.98 | |
Neurocrine Biosciences (NBIX) | 2.1 | $7.4M | 965k | 7.64 | |
Progenics Pharmaceuticals | 1.9 | $6.4M | 1.2M | 5.46 | |
BioMimetic Therapeutics | 1.9 | $6.4M | 501k | 12.70 | |
Auxilium Pharmaceuticals | 1.8 | $6.3M | 300k | 21.10 | |
Spdr S&p 500 Etf (SPY) | 1.8 | $6.3M | 50k | 125.76 | |
AVI BioPharma ComStk Usd0.0001 | 1.6 | $5.4M | 2.6M | 2.12 | |
Watson Pharmaceuticals | 1.5 | $5.2M | 100k | 51.65 | |
Shire | 1.5 | $5.1M | 70k | 72.39 | |
Teva Pharmaceutical Industries (TEVA) | 1.4 | $4.7M | 90k | 52.13 | |
Uroplasty | 1.2 | $4.2M | 1.0M | 4.03 | |
3SBio (SSRX) | 1.2 | $4.1M | 271k | 15.18 | |
Orexigen Therapeutics | 1.2 | $4.0M | 500k | 8.08 | |
Gilead Sciences (GILD) | 1.2 | $4.0M | 110k | 36.24 | |
Keryx Biopharmaceuticals | 1.1 | $3.8M | 823k | 4.58 | |
ProAssurance Corporation (PRA) | 0.9 | $3.0M | 50k | 60.60 | |
Capital Senior Living Corporation | 0.8 | $2.8M | 413k | 6.70 | |
PDL BioPharma | 0.8 | $2.7M | 439k | 6.23 | |
Endo Pharmaceuticals | 0.7 | $2.5M | 70k | 35.71 | |
Warner Chilcott Plc - | 0.7 | $2.3M | 100k | 22.56 | |
Incyte Corporation (INCY) | 0.6 | $2.0M | 120k | 16.56 | |
UnitedHealth (UNH) | 0.5 | $1.8M | 50k | 36.12 | |
Trinity Biotech | 0.5 | $1.7M | 192k | 8.80 | |
Ym Biosciences | 0.5 | $1.6M | 690k | 2.33 | |
Momenta Pharmaceuticals | 0.4 | $1.5M | 100k | 14.97 | |
Sabra Health Care REIT (SBRA) | 0.4 | $1.3M | 72k | 18.40 | |
Nektar Therapeutics (NKTR) | 0.4 | $1.3M | 100k | 12.85 | |
Arena Pharmaceuticals | 0.3 | $1.0M | 600k | 1.72 | |
Response Genetics (RGDXQ) | 0.3 | $1000k | 403k | 2.48 | |
China Nuokang Bio-Pharmaceutical (NKBP) | 0.3 | $965k | 255k | 3.79 | |
MAKO Surgical | 0.2 | $761k | 50k | 15.22 | |
XenoPort | 0.2 | $639k | 75k | 8.52 | |
Thoratec Corporation | 0.2 | $589k | 21k | 28.32 | |
Palomar Medical Technologies | 0.2 | $568k | 40k | 14.20 | |
Columbia Laboratories | 0.2 | $568k | 250k | 2.27 | |
Immunomedics | 0.2 | $537k | 150k | 3.58 | |
Raptor Pharmaceutical | 0.2 | $546k | 150k | 3.64 | |
Ariad Pharmaceuticals | 0.1 | $510k | 100k | 5.10 | |
Sun Healthcare Group | 0.1 | $527k | 42k | 12.65 | |
Cynosure | 0.1 | $415k | 41k | 10.24 | |
Stereotaxis | 0.1 | $287k | 75k | 3.83 | |
LeMaitre Vascular (LMAT) | 0.1 | $271k | 40k | 6.78 | |
Amarin Corporation | 0.1 | $246k | 30k | 8.20 | |
athenahealth | 0.1 | $221k | 5.4k | 40.93 | |
Osiris Therapeutics | 0.0 | $85k | 11k | 7.77 | |
pSivida | 0.0 | $70k | 14k | 5.09 | |
Santarus | 0.0 | $51k | 16k | 3.29 | |
Nile Therapeutics Inc *w exp 99/99/999 | 0.0 | $42k | 150k | 0.28 | |
Combimatrix Corporation *w exp 05/01/201 | 0.0 | $0 | 50k | 0.00 |